💊Establish mass production technology of Toyobo and HMT, enzymes for depression related biomarkers Toyobo and Human Metabolome Technologies have established mass-production technologies for enzymes used for measuring depression-related biomarkers through collaborative research.
💊Completion of Acquisition of NeuroDerm (100% Ownership) 20171018
💡Development of new technology that suppresses environmental burden that allows pretreatment in resin plating and formation of underlayer under vacuum